ONCOPOOL - a European database for 16,944 cases of breast cancer.
暂无分享,去创建一个
M. J. van de Vijver | G. Ball | I. Ellis | R. Mansel | R. Blamey | S. Pinder | R. Nicholson | M. Kerin | K. Holli | R. Jakesz | J. Gee | A. Fourquet | T. Pieńkowski | L. Cataliotti | M. Sundquist | M. Blichert‐Toft | M. V. D. Vijver | B. Hornmark-Stenstam | Michael J. Kerin | Robert E. Mansel | I. O. Ellis | Graham Ball | Kaija Holli | Sarah E Pinder
[1] J. Lundin. The Nottingham Prognostic Index - from relative to absolute risk prediction. , 2007, European journal of cancer.
[2] R W Blamey,et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. , 2007, European journal of cancer.
[3] G. Ball,et al. Reading the prognosis of the individual with breast cancer. , 2007, European journal of cancer.
[4] C. Perou,et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.
[5] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[6] V. Kataja,et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. , 2004, JAMA.
[7] C. Axelsson,et al. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG) , 2004, Breast Cancer Research and Treatment.
[8] I. Ellis,et al. Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. , 2001, European journal of cancer.
[9] C. Giardina,et al. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. , 2001, European journal of cancer.
[10] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[11] G M Clark,et al. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[13] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[14] S. Pinder,et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma , 1995, Histopathology.
[15] V. Beral,et al. Sudden fall in breast cancer death rates in England and Wales , 1995, The Lancet.
[16] L S Freedman,et al. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index , 1991, Cancer.
[17] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[18] R. Blamey,et al. A prognostic index in primary breast cancer. , 1982, British Journal of Cancer.
[19] R. Blamey,et al. Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. , 1978, British Journal of Cancer.